Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors (Q45880904)

17 December 2017

title

Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors (English)

1 reference

17 December 2017

Herpes simplex virus type 1

1 reference

1 reference

1 reference

1 reference

Rueger MA

1

1 reference

17 December 2017

Winkeler A

2

1 reference

17 December 2017

Miletic H

3

1 reference

17 December 2017

Kaestle C

4

1 reference

17 December 2017

Richter R

5

1 reference

17 December 2017

Schneider G

6

1 reference

17 December 2017

Hilker R

7

1 reference

17 December 2017

Heneka MT

8

1 reference

17 December 2017

Ernestus RI

9

1 reference

17 December 2017

Hampl JA

10

1 reference

17 December 2017

Fraefel C

11

1 reference

17 December 2017

Jacobs AH

12

1 reference

17 December 2017

language of work or name

1 reference

1 April 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

588-596

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302462

exact match

0 references

cites work

Histopathology, classification, and grading of gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Viral vectors for gene delivery to the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

A cosmid-based system for constructing mutants of herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Gene delivery using herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

HSV-1 amplicon peptide display vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

Proliferative activity and in vitro replication of HSV1716 in human metastatic brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

MRI of transgene expression: correlation to therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302462

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302462

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017